Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
Health Quality Ontario
Record ID 32016001145
English
Authors' recommendations:
The Ontario Health Technology Advisory Committee recommends that transcatheter aortic valve implantation be publicly funded in patients with severe symptomatic degenerative aortic valve stenosis:
o Who are not candidates for surgical aortic valve replacement or
o Who have an estimated risk of mortality of 8% or greater within 30 days of surgery, as determined by a multidisciplinary cardiac team after evaluating the patient's Society of Thoracic Surgeons risk assessment score and other patient characteristics
The Ontario Health Technology Advisory Committee recommends that transcatheter aortic valve implantation be offered only in selected hospitals, as determined by the Cardiac Care Network of Ontario
Details
Project Status:
Completed
Year Published:
2016
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/evidence/reports/recommendation-tavi-aortic-valve-stenosis-101116-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Transcatheter Aortic Valve Replacement
- Aortic Valve Stenosis
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario (HQO)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.